ImetelChat

Fisher,

I understand what you are saying. Both you and biopearl have made valid points and I appreciate your insight. In order to avoid any confusion I should perhaps observe that I have no desire to sell GERN. In fact, it is by far the most interesting stock I own.

<< Sargasso, what is it that you want exactly? >>

What do I want? What I really want? I want GERN to tell me in no uncertain terms that I will make a fortune off the stock. That's what I want. <grin>

<< I would advice you not to go into the paranoia we continously see at some other message board. >> Your comments make sense to me and are appreciated. But I don’t think my question indicates I’m going into paranoia. I’m not interested in paranoia or unreasonable fear. Rather I think I’m asking a l...

This is no doubt a dumb question. But I will ask it anyway. It’s my understanding that imetelstat acts quickly. It seems to me, therefore, before too much longer GERN/Janssen/JNJ will obtain some idea of how patients are responding to the drug in the present clinical trials. But the results of those...

It seems to me the recent spectacular price action in CPXX is very encouraging for GERN shareholders. Although admittedly not exactly comparable it appears to me that GERN has developed a far superior drug. It is also interesting to note that “the blood cancer market is already valued at over $24 bi...

Thanks for your thoughtful reply. I appreciate your insight. I hold a substantial position in GERN. I believe Geron has developed an important cancer drug, that the drug will be approved and will most likely be used in other indications. In other words I see imetelstat as a platform drug. Investment...

There appears to be considerable concern on the Yahoo GERN message board that GERN will make a premature purchase of an early development biotech company resulting in significant dilution of GERN. The CEO is in the habit of speaking of this possibility rather often. This worry is repeated in the art...